Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...
Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...
Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Linfoma</strong> <strong>no</strong> <strong>Hodgkin</strong> <strong>en</strong> <strong>adultos</strong>: Tratami<strong>en</strong>to (<strong>PDQ®</strong>) - <strong>National</strong> Cancer Institute<br />
115 (18): 3664-70, 2010. [PUBMED Abstract]<br />
180. Shimada K, Matsue K, Yamamoto K, et al.: Retrospective analysis of intravascular large B-cell lymphoma<br />
treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol<br />
26 (19): 3189-95, 2008. [PUBMED Abstract]<br />
181. Ponzoni M, Ferreri AJ, Campo E, et al.: Definition, diag<strong>no</strong>sis, and managem<strong>en</strong>t of intravascular large Bcell<br />
lymphoma: proposals and perspectives from an international cons<strong>en</strong>sus meeting. J Clin Oncol 25 (21):<br />
3168-73, 2007. [PUBMED Abstract]<br />
182. Blum KA, Lozanski G, Byrd JC: Adult Burkitt leukemia and lymphoma. Blood 104 (10): 3009-20, 2004.<br />
[PUBMED Abstract]<br />
183. Onciu M, Schlette E, Zhou Y, et al.: Secondary chromosomal ab<strong>no</strong>rmalities predict outcome in pediatric<br />
and adult high-stage Burkitt lymphoma. Cancer 107 (5): 1084-92, 2006. [PUBMED Abstract]<br />
184. Macpherson N, Lesack D, Klasa R, et al.: Small <strong>no</strong>ncleaved, <strong>no</strong>n-Burkitt's (Burkit-Like) lymphoma:<br />
cytog<strong>en</strong>etics predict outcome and reflect clinical pres<strong>en</strong>tation. J Clin Oncol 17 (5): 1558-67, 1999. [PUBMED<br />
Abstract]<br />
185. Dave SS, Fu K, Wright GW, et al.: Molecular diag<strong>no</strong>sis of Burkitt's lymphoma. N Engl J Med 354 (23):<br />
2431-42, 2006. [PUBMED Abstract]<br />
186. Hummel M, B<strong>en</strong>tink S, Berger H, et al.: A biologic definition of Burkitt's lymphoma from transcriptional<br />
and ge<strong>no</strong>mic profiling. N Engl J Med 354 (23): 2419-30, 2006. [PUBMED Abstract]<br />
187. Longo DL, Duffey PL, Jaffe ES, et al.: Diffuse small <strong>no</strong>ncleaved-cell, <strong>no</strong>n-Burkitt's lymphoma in adults: a<br />
high-grade lymphoma responsive to ProMACE-based combination chemotherapy. J Clin Oncol 12 (10):<br />
2153-9, 1994. [PUBMED Abstract]<br />
188. McMaster ML, Greer JP, Greco FA, et al.: Effective treatm<strong>en</strong>t of small-<strong>no</strong>ncleaved-cell lymphoma with<br />
high-int<strong>en</strong>sity, brief-duration chemotherapy. J Clin Oncol 9 (6): 941-6, 1991. [PUBMED Abstract]<br />
189. Thomas DA, Faderl S, O'Bri<strong>en</strong> S, et al.: Chemoimmu<strong>no</strong>therapy with hyper-CVAD plus rituximab for the<br />
treatm<strong>en</strong>t of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 106 (7):<br />
1569-80, 2006. [PUBMED Abstract]<br />
190. Soussain C, Patte C, Ostro<strong>no</strong>ff M, et al.: Small <strong>no</strong>ncleaved cell lymphoma and leukemia in adults. A<br />
retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85 (3): 664-74, 1995.<br />
[PUBMED Abstract]<br />
191. Magrath I, Adde M, Shad A, et al.: Adults and childr<strong>en</strong> with small <strong>no</strong>n-cleaved-cell lymphoma have a<br />
similar excell<strong>en</strong>t outcome wh<strong>en</strong> treated with the same chemotherapy regim<strong>en</strong>. J Clin Oncol 14 (3): 925-34,<br />
1996. [PUBMED Abstract]<br />
192. Adde M, Shad A, V<strong>en</strong>zon D, et al.: Additional chemotherapy ag<strong>en</strong>ts improve treatm<strong>en</strong>t outcome for<br />
childr<strong>en</strong> and adults with advanced B-cell lymphomas. Semin Oncol 25 (2 Suppl 4): 33-9; discussion 45-8,<br />
1998. [PUBMED Abstract]<br />
193. Hoelzer D, Ludwig WD, Thiel E, et al.: Improved outcome in adult B-cell acute lymphoblastic leukemia.<br />
Blood 87 (2): 495-508, 1996. [PUBMED Abstract]<br />
194. Lee EJ, Petroni GR, Schiffer CA, et al.: Brief-duration high-int<strong>en</strong>sity chemotherapy for pati<strong>en</strong>ts with small<br />
<strong>no</strong>ncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group<br />
B study 9251. J Clin Oncol 19 (20): 4014-22, 2001. [PUBMED Abstract]<br />
195. Mead GM, Sydes MR, Walewski J, et al.: An international evaluation of CODOX-M and CODOX-M<br />
alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06<br />
study. Ann Oncol 13 (8): 1264-74, 2002. [PUBMED Abstract]<br />
196. Freedman AS, Takvorian T, Anderson KC, et al.: Autologous bone marrow transplantation in B-cell <strong>no</strong>n-<br />
<strong>Hodgkin</strong>'s lymphoma: very low treatm<strong>en</strong>t-related mortality in 100 pati<strong>en</strong>ts in s<strong>en</strong>sitive relapse. J Clin Oncol<br />
8 (5): 784-91, 1990. [PUBMED Abstract]<br />
197. Sweet<strong>en</strong>ham JW, Pearce R, Philip T, et al.: High-dose therapy and autologous bone marrow transplantation<br />
for intermediate and high grade <strong>no</strong>n-<strong>Hodgkin</strong>'s lymphoma in pati<strong>en</strong>ts aged 55 years and over: results from<br />
the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party. Bone<br />
Marrow Transplant 14 (6): 981-7, 1994. [PUBMED Abstract]<br />
file:///Users/mauriciolema/Docum<strong>en</strong>ts/MLMGuias_09_<strong>Linfoma</strong>No<strong>Hodgkin</strong>.webarchive<br />
29/09/11 6:15<br />
Página 23 de 61
Change language